BioMarin Pharmaceutical (BMRN) News Today $53.85 -0.84 (-1.54%) Closing price 10/9/2025 04:00 PM EasternExtended Trading$54.52 +0.67 (+1.25%) As of 10/9/2025 07:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BMRN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period BioMarin Pharmaceutical's (BMRN) "Sell (D+)" Rating Reaffirmed at Weiss RatingsOctober 9 at 7:01 PM | marketbeat.comWhere is BioMarin Pharmaceutical (BMRN) Headed According to Analysts?October 8 at 5:38 AM | finance.yahoo.comWhere is BioMarin Pharmaceutical (BMRN) Headed According to Analysts?October 8 at 5:38 AM | finance.yahoo.comRobeco Institutional Asset Management B.V. Increases Stake in BioMarin Pharmaceutical Inc. $BMRNOctober 4, 2025 | marketbeat.comCan BioMarin (BMRN) Turn PALYNZIQ Success Into a Stronger Rare Disease Growth Story?October 3, 2025 | finance.yahoo.comJ. Safra Sarasin Holding AG Boosts Stake in BioMarin Pharmaceutical Inc. $BMRNOctober 3, 2025 | marketbeat.comGrowth and Pipeline Keep BioMarin Pharmaceutical Inc. (BMRN) Attractive for InvestorsOctober 2, 2025 | insidermonkey.comNew Wave Wealth Advisors LLC Raises Position in BioMarin Pharmaceutical Inc. $BMRNOctober 2, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. (BMRN) Hits Its 52-Week LowOctober 1, 2025 | insidermonkey.comPGGM Investments Has $28.47 Million Holdings in BioMarin Pharmaceutical Inc. $BMRNOctober 1, 2025 | marketbeat.comBioMarin: Valuation, Growth, And The Pipeline May Outweigh TransCon Competition And Regulatory RisksSeptember 30, 2025 | seekingalpha.comRaymond James Maintains a Buy Rating on BioMarin Pharmaceutical (BMRN), Sets a $85 PTSeptember 30, 2025 | finance.yahoo.comTealwood Asset Management Inc. Increases Holdings in BioMarin Pharmaceutical Inc. $BMRNSeptember 30, 2025 | marketbeat.comWealth Enhancement Advisory Services LLC Raises Stock Holdings in BioMarin Pharmaceutical Inc. $BMRNSeptember 26, 2025 | marketbeat.comBioMarin Pharmaceutical (NASDAQ:BMRN) Reaches New 12-Month Low - Time to Sell?September 23, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. $BMRN Shares Acquired by Covea FinanceSeptember 23, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. $BMRN Stock Position Increased by Assenagon Asset Management S.A.September 21, 2025 | marketbeat.comPerpetual Ltd Purchases Shares of 13,980 BioMarin Pharmaceutical Inc. $BMRNSeptember 21, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Given Average Rating of "Moderate Buy" by BrokeragesSeptember 21, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Sees Significant Increase in Short InterestSeptember 19, 2025 | marketbeat.comStrs Ohio Takes Position in BioMarin Pharmaceutical Inc. $BMRNSeptember 19, 2025 | marketbeat.comIs New VOXZOGO and PALYNZIQ Data Shifting the Investment Narrative for BioMarin Pharmaceutical (BMRN)?September 18, 2025 | finance.yahoo.comBioMarin Pharmaceutical Inc.’s (BMRN) Phenylketonuria Candidate Drug Impresses in Phase 3 TrialsSeptember 18, 2025 | msn.comA Fresh Look at BioMarin Pharmaceutical (BMRN) Valuation Following New VOXZOGO and PALYNZIQ Clinical DataSeptember 17, 2025 | finance.yahoo.comBMO Capital Reiterates a Buy on BioMarin Pharmaceutical (BMRN)September 17, 2025 | insidermonkey.comAcadian Asset Management LLC Has $1.70 Million Holdings in BioMarin Pharmaceutical Inc. $BMRNSeptember 17, 2025 | marketbeat.comIntech Investment Management LLC Has $2.27 Million Stake in BioMarin Pharmaceutical Inc. $BMRNSeptember 17, 2025 | marketbeat.comReflecting On Therapeutics Stocks’ Q2 Earnings: BioMarin Pharmaceutical (NASDAQ:BMRN)September 16, 2025 | finance.yahoo.comNew Study Results Highlight BioMarin’s VOXZOGO Efficacy in ChildrenSeptember 16, 2025 | msn.comBioMarin Pharmaceutical Inc. (BMRN): A Bull Case TheorySeptember 16, 2025 | finance.yahoo.comWesbanco Bank Inc. Acquires 19,000 Shares of BioMarin Pharmaceutical Inc. $BMRNSeptember 16, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. $BMRN Shares Purchased by Goldman Sachs Group Inc.September 15, 2025 | marketbeat.comMIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $3.72 Million Stock Holdings in BioMarin Pharmaceutical Inc. $BMRNSeptember 15, 2025 | marketbeat.comUBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Acquires 9,837 Shares of BioMarin Pharmaceutical Inc. $BMRNSeptember 15, 2025 | marketbeat.comBioMarin Pharmaceutical (NASDAQ:BMRN) Upgraded by Wall Street Zen to Strong-Buy RatingSeptember 15, 2025 | marketbeat.comAlliancebernstein L.P. Grows Stock Position in BioMarin Pharmaceutical Inc. $BMRNSeptember 13, 2025 | marketbeat.comAnalysts Are Bullish on These Healthcare Stocks: BioMarin Pharmaceutical (BMRN), Black Diamond Therapeutics (BDTX)September 12, 2025 | theglobeandmail.comBayforest Capital Ltd Invests $552,000 in BioMarin Pharmaceutical Inc. $BMRNSeptember 12, 2025 | marketbeat.comBioMarin Pharmaceutical (NASDAQ:BMRN) Now Covered by Analysts at HC WainwrightSeptember 10, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. $BMRN Shares Sold by Clearline Capital LPSeptember 10, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. (BMRN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 9, 2025 | seekingalpha.comBioMarin Pharmaceutical (BMRN) Receives a Hold from William BlairSeptember 9, 2025 | theglobeandmail.comTeza Capital Management LLC Acquires New Position in BioMarin Pharmaceutical Inc. $BMRNSeptember 9, 2025 | marketbeat.comHC Wainwright & Co. Initiates Coverage of BioMarin Pharmaceutical (BMRN) with Neutral RecommendationSeptember 9, 2025 | msn.comForecasting The Future: 5 Analyst Projections For BioMarin PharmaceuticalSeptember 9, 2025 | benzinga.comWhy BioMarin Pharmaceutical (BMRN) Stock Is Down TodaySeptember 9, 2025 | msn.comBioMarin Pharmaceutical Inc. $BMRN Stake Increased by Federation des caisses Desjardins du QuebecSeptember 9, 2025 | marketbeat.comVident Advisory LLC Makes New $427,000 Investment in BioMarin Pharmaceutical Inc. $BMRNSeptember 9, 2025 | marketbeat.comBioMarin Pharmaceutical: Promising Growth with Palynziq Expansion and Robust Product PipelineSeptember 8, 2025 | tipranks.comBioMarin Shares New Data Reinforcing Its Leadership in Bone Health at the American Society for Bone and Mineral Research Annual MeetingSeptember 8, 2025 | prnewswire.com Get BioMarin Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for BMRN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BMRN Media Mentions By Week BMRN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BMRN News Sentiment▼1.070.77▲Average Medical News Sentiment BMRN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BMRN Articles This Week▼914▲BMRN Articles Average Week Get the Latest News and Ratings for BMRN and Related Stocks Enter your email address to receive the latest news and analysts' ratings for BioMarin Pharmaceutical and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies BIIB News Today UTHR News Today INCY News Today NBIX News Today IONS News Today EXAS News Today EXEL News Today MDGL News Today RGEN News Today HALO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BMRN) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredNvidia and AMD just surged. But this setup was already winning.Last week, Nvidia and AMD stock soared as export restrictions eased. Nvidia alone gained nearly 5% in a sin...Timothy Sykes | SponsoredHave you heard of the Texas Royalty Plan?There is a backdoor way you could collect a check, four times a year, thanks to the exploding oil industry in ...Brownstone Research | SponsoredHow to Cash In on Trump’s Digital Current - Move By This ThursdayBitcoin Breakout: What Most Investors Are Missing Washington just approved more crypto legislation in 90 da...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioMarin Pharmaceutical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioMarin Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
